Malonic Acid

Malonic Acid

SCHEMBL66611

O=C([O-])CC(=O)[O-].[H+].[H+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Malonic Acid SCHEMBL106339 0.96
Malonic Acid SCHEMBL106381 0.96
Malonic Acid SCHEMBL107186 0.96
Malonic Acid SCHEMBL3190631 0.91
Malonic Acid SCHEMBL21815638 0.91 CA4 (0.91)
Malonic Acid SCHEMBL9184127 0.91
Malonic Acid SCHEMBL9571038 0.91
Malonic Acid SCHEMBL21815790 0.91 CA4 (0.91)
Malonic Acid SCHEMBL5142880 0.91 CA4 (0.91)
Malonic Acid SCHEMBL2475920 0.91 CA4 (0.91)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 299 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119546295-A Medical active substance 炎症药物有限责任公司 2025-02-28 CN claimed
CN-118414729-A Modified current collector for secondary battery 广东省皓智科技有限公司 2024-07-30 CN claimed
EP-3316890-B1 NOVEL BREATHING CONTROL MODULATING COMPOUNDS, AND METHODS OF MAKING AND USING SAME NEURAD LTD (IL) 2023-09-06 EP claimed
CN-111295369-B Carbonic acid adducts 炎症药物有限责任公司 2023-07-25 CN claimed
CN-115697318-A Medical active substance 炎症药物有限责任公司 2023-02-03 CN claimed
CN-111295369-A Carbonic acid adducts JENCLUSTER 有限责任公司 2020-06-16 CN claimed
EP-3089983-B1 WATER SOLUBLE CRYSTALLIN SALTS OF CERTAIN HARRINGTONINES UNAMBIGUOUSLY PROTONATED ON THEIR ALKALOID NITROGEN AND THEIR USE AS CHEMOTHERAPEUTIC DRUGS ROBIN JEAN PIERRE (CH) 2020-03-25 EP claimed
EP-3019500-B1 NALMEFENE SALTS AS MEDICAMENTS FOR REDUCING ALCOHOL CONSUMPTION OR FOR PREVENTING EXCESSIVE ALCOHOL CONSUMPTION H LUNDBECK AS (DK) 2019-09-11 EP claimed
US-20190161493-A1 NOVEL HARRINGTONINES SALTS IN THE CRYSTALLINE STATE, THEIR USE FOR THE PURIFICATION OF THE CORRESPONDING DRUG SUBSTANCE AND AS CHEMOTHERAPEUTIC AGENTS GIVEN ALONE OR COMBINED WITH RADIOTHERAPY OR AS IMMUNOMODULATING AGENTS ROBIN JEAN PIERRE (CH) 2019-05-30 US claimed
US-10294228-B2 Breathing control modulating compounds, and methods of making and using same NEURAD LTD. (IL) 2019-05-21 US claimed
EP-1912938-A2 SALTS OF VILDAGLIPTIN Novartis AG (CH) 2008-04-23 EP claimed
WO-2008000839-A1 QUINOLINONE DERIVATIVES AND THEIR PHARMACEUTICAL COMPOSITIONS NOVARTIS AG (CH) 2008-01-03 WO claimed
WO-2007019255-A2 SALTS OF VILDAGLIPTIN NOVARTIS AG (CH) 2007-02-15 WO claimed
US-20060281759-A1 selective serotonin receptor antagonists used for the treatment of psychological disorders such as schizophrenia and bipolar disorders, as anxiolytic agents and antidepressants; improved water solubility; side effect reduction; H. LUNDBECK A/S (DK) 2006-12-14 US claimed
EP-1658277-A1 SUCCINATE AND MALONATE SALT OF TRANS-4-(IR,3S)-6-CHLORO-3-PHENYLINDAN-1-YL)-1,2,2-TRIMETHYLPIPERAZINE AND THE USE AS A MEDICAMENT H. Lundbeck A/S (DK) 2006-05-24 EP claimed
WO-2005016900-A1 SUCCINATE AND MALONATE SALT OF TRANS-4-(IR,3S)-6-CHLORO-3-PHENYLINDAN-1-YL)-1,2,2-TRIMETHYLPIPERAZINE AND THE USE AS A MEDICAMENT H. LUNDBECK A/S (DK) 2005-02-24 WO claimed
EP-0931083-A4 PROCESS FOR PRODUCING ECTEINASCIDIN COMPOUNDS HARVARD COLLEGE (US) 2000-05-24 EP claimed
EP-0931083-A1 PROCESS FOR PRODUCING ECTEINASCIDIN COMPOUNDS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1999-07-28 EP claimed
WO-1998012198-A1 PROCESS FOR PRODUCING ECTEINASCIDIN COMPOUNDS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1998-03-26 WO claimed
US-5256653-A Pharmaceutical preparations containing platinum complexes/phosphonic acid liquid and processes for their use HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1993-10-26 US claimed